Kck Ltd. Neuro Pace Inc Transaction History
Kck Ltd.
- $74.9 Million
- Q4 2024
A detailed history of Kck Ltd. transactions in Neuro Pace Inc stock. As of the latest transaction made, Kck Ltd. holds 5,270,845 shares of NPCE stock, worth $75.1 Million. This represents 78.74% of its overall portfolio holdings.
Number of Shares
5,270,845
Previous 5,621,111
6.23%
Holding current value
$75.1 Million
Previous $54.7 Million
7.84%
% of portfolio
78.74%
Previous 77.74%
Shares
2 transactions
Others Institutions Holding NPCE
# of Institutions
53Shares Held
20.9MCall Options Held
1.3KPut Options Held
100-
Orbimed Advisors LLC San Diego, CA3.41MShares$48.5 Million0.56% of portfolio
-
Morgan Stanley New York, NY2.49MShares$35.5 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$34.6 Million1.44% of portfolio
-
Kent Lake Pr LLC Anasco, PR1.25MShares$17.8 Million3.46% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.14MShares$16.3 Million3.99% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $354M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...